Annals Of Internal Medicine, 154
Leah Liszak, Meghan Etsey, Yun Weisholtz, MD-PhD on behalf of AMWA Gender Equity Task Force Diabetes care has entered an era of precision therapeutics: we no longer treat blood sugar as a single entity but rather tailor regimens to comorbidities, risk profiles, and, critically, individual biology
503B facilities are outsourcing facilities that compound drugs in larger quantities for healthcare facilities - they're subject to additional federal FDA oversight and voluntary inspection, which generally means higher manufacturing quality standards
The bottom line Nausea is a common side effect when taking a GLP-1 because of the way the medication slows down digestion
So, its huge
When you quit abruptly, ghrelin levels skyrocket , leading to intense hunger and constant thoughts about food